TMKXY -1.97% Stock Charts $TMKXY TMK ADR (OTC) Last

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Understanding the Alarming Trends in Breast Cancer Recent research has uncovered concerning statistics regarding breast cancer in younger women, specifically those aged 18 to 49. A comprehensive study conducted across multiple outpatient facilities has revealed a significant portion of breast cancer diagnoses among this demographic, raising urgent questions about current...

Asseta Unveils Its Rebrand and Advanced AI Offerings In a significant development, Prismatic has rebranded to become Asseta, a transformation that underscores its dedication to providing innovative financial management solutions tailored specifically for family offices. This transition not only marks a shift in branding but signals a deeper commitment to enhancing the...

The Surge in Microsoft Options Trading Investors with substantial capital have adopted a bullish approach towards Microsoft (NASDAQ: MSFT). This trend is essential for both institutional and retail traders alike to grasp their positions in the market. What Unusual Trading Movements Reveal Today, a noteworthy surge in options trades for Microsoft caught our attention...

Eilean Therapeutics Progresses ZE74-0282 into Clinical Trials Eilean Therapeutics has announced an exciting advancement in their pipeline with the development of ZE74-0282, now entering its first-in-human clinical trials. This innovative treatment aims to battle myeloproliferative neoplasms, particularly focusing on the JAK2 V617F mutated variant that poses significant...

Supermicro's Open Storage Summit: A Game Changer The Open Storage Summit, hosted by Super Micro Computer, Inc. (SMCI), is gearing up to make waves in the tech industry. This year marks the sixth installment of the summit, which will be running from August 12 to August 28, featuring nine insightful sessions and the participation of 23 companies and 40 speakers. The event...